The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
| Autor: | Luke Bereznicki, Endalkachew Alamneh, Leanne Chalmers |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
Time Factors Administration Oral Kaplan-Meier Estimate 030204 cardiovascular system & hematology 0302 clinical medicine Drug Utilization Review Risk Factors Antithrombotic Atrial Fibrillation Medicine Electronic Health Records Pharmacology (medical) 030212 general & internal medicine Practice Patterns Physicians' Stroke Aged 80 and over Medical record Atrial fibrillation General Medicine Middle Aged Treatment Outcome Female Cardiology and Cardiovascular Medicine medicine.drug medicine.medical_specialty Hemorrhage Drug Prescriptions Risk Assessment Tasmania 03 medical and health sciences Fibrinolytic Agents Internal medicine Humans Intensive care medicine Contraindication Blood Coagulation Aged Retrospective Studies Pharmacology business.industry Warfarin Anticoagulants Retrospective cohort study Secondary diagnosis medicine.disease business Platelet Aggregation Inhibitors |
| Zdroj: | Cardiovascular therapeutics. 35(3) |
| ISSN: | 1755-5922 |
| Popis: | SummaryIntroduction Contemporary Australian data regarding antithrombotic prescribing patterns following approval of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) are limited. Aim The aim of this study was to assess antithrombotic prescribing patterns before, during, and after the clinical introduction of DOACs. Methods Using digital medical records, this retrospective cohort study included all patients with AF as a primary or secondary diagnosis who were admitted to the Royal Hobart Hospital, Tasmania, Australia, between January 2011 and July 2015. Results Antithrombotic agents were prescribed for 2078 (91.9%) of 2261 patients without documented contraindication to therapy. Higher rates of OAC prescribing were observed following government subsidization of DOACs in Quarter 3 (Q3) 2013 than anticoagulation rates in the prior quarters (54.4% in Q3, 2013, to 68.1% in Q2, 2015, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|